Operating and Financial Results for the Third Quarter 2019
November 12, 2019 at 4:05 PM EST
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Nov. 12, 2019-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the third quarter of 2019 and provided a business update.
Recent Highlights
Anthony Fernando appointed President and CEO on November 8, 2019
Total revenue of $2.0 million in the third quarter of 2019
Amended AutoLap Asset Sale terms, the Company now expects total of $17 million
Repaid Term Loan providing simplified balance sheet and financial flexibility
Announced proposed reverse stock split to be voted upon at a Special Meeting of Stockholders
|